Literature DB >> 8834870

Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.

B W Petschow1, R P Batema, L L Ford.   

Abstract

Previous studies have shown that various short- and medium-chain free fatty acids (FFAs) and their corresponding monoacylglycerol esters (MGs) have antibacterial activity in vitro against primarily gram-positive bacteria. More recent studies have also shown that the growth of Helicobacter spp. is inhibited by linoleic acid and arachidonic acid. The purpose of the present study was to evaluate the susceptibility of Helicobacter pylori to the in vitro bactericidal properties of medium-chain MGs and FFAs. Incubation of H. pylori with saturated MGs, ranging in carbon chain length from C10:0 to C14:0, at 1 mM caused a 4-log-unit or greater reduction in the number of viable bacteria after exposure for 1 h. Lower levels of bactericidal activity were observed with C9:0, C15:0, and C16:0 MGs. In contrast, lauric acid (C12:0) was the only medium-chain saturated FFA with bactericidal activity against H. pylori. The MGs and FFAs were bactericidal after incubation for as little as 15 min at neutral or acidic pHs. Higher levels of MGs and FFAs were required for bactericidal activity in the presence of higher amounts of protein in liquid diets. We also found that the frequency of spontaneous development of resistance by H. pylori was higher for metronidazole and tetracycline (10(-5) to 10(-6)) than for C10:0 MG, C12:0 MG, and C12:0 FFA (< 10(-8)). Collectively, our data demonstrate that H. pylori is rapidly inactivated by medium-chain MGs and lauric acid and exhibits a relatively low frequency of spontaneous development of resistance to the bactericidal activity of MGs. Further studies are needed to establish whether MGs may be useful either alone or with other known therapeutic agents in the management of H. pylori infections in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834870      PMCID: PMC163106     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Studies of intestinal digestion and absorption in the human.

Authors:  B BORGSTROM; A DAHLQVIST; G LUNDH; J SJOVALL
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

2.  Effect of the Chemical Constitution of Soaps upon their Germicidal Properties.

Authors:  M Bayliss
Journal:  J Bacteriol       Date:  1936-05       Impact factor: 3.490

3.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

4.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

5.  Bactericidal effects of polyunsaturated fatty acids.

Authors:  H R Knapp; M A Melly
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

6.  Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori.

Authors:  S L Hazell; D Y Graham
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Physicochemical effects of long chain fatty acids on bacterial cells and their protoplasts.

Authors:  H Galbraith; T B Miller
Journal:  J Appl Bacteriol       Date:  1973-12

8.  Effect of long chain fatty acids on bacterial respiration and amino acid uptake.

Authors:  H Galbraith; T B Miller
Journal:  J Appl Bacteriol       Date:  1973-12

Review 9.  Treatment strategies for Helicobacter pylori infection.

Authors:  B J Marshall
Journal:  Gastroenterol Clin North Am       Date:  1993-03       Impact factor: 3.806

Review 10.  Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia.

Authors:  J G Penston
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

View more
  35 in total

1.  Bactericidal activities of milk lipids.

Authors:  R C Sprong; M F Hulstein; R Van der Meer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro.

Authors:  Paran Rayan; Deborah Stenzel; Pauline Ann McDonnell
Journal:  Parasitol Res       Date:  2005-07-01       Impact factor: 2.289

3.  Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.

Authors:  Harry G Preuss; Bobby Echard; Mary Enig; Itzhak Brook; Thomas B Elliott
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

4.  Growth and survival of Helicobacter pylori in defined medium and susceptibility to Brij 78.

Authors:  N Albertson; I Wenngren; J E Sjöström
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori.

Authors:  Marygorret Obonyo; Li Zhang; Soracha Thamphiwatana; Dissaya Pornpattananangkul; Victoria Fu; Liangfang Zhang
Journal:  Mol Pharm       Date:  2012-08-06       Impact factor: 4.939

6.  Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus.

Authors:  J A Kelsey; K W Bayles; B Shafii; M A McGuire
Journal:  Lipids       Date:  2006-10       Impact factor: 1.880

7.  In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.

Authors:  Dissaya Pornpattananangkul; Victoria Fu; Soracha Thamphiwatana; Li Zhang; Michael Chen; James Vecchio; Weiwei Gao; Chun-Ming Huang; Liangfang Zhang
Journal:  Adv Healthc Mater       Date:  2013-03-12       Impact factor: 9.933

Review 8.  Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Authors:  Valerie J Smith; Andrew P Desbois; Elisabeth A Dyrynda
Journal:  Mar Drugs       Date:  2010-04-14       Impact factor: 5.118

9.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

10.  A fatty acid from the diatom Phaeodactylum tricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcus aureus (MRSA).

Authors:  Andrew P Desbois; Andrew Mearns-Spragg; Valerie J Smith
Journal:  Mar Biotechnol (NY)       Date:  2008-06-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.